Associate Director, Key Accounts & Market Access

LEO Pharma; Denver (CO); On-site; USD 175,000 - 250,000; Full time

Job summary

LEO Pharma in Denver, CO, is seeking an Associate Director, Key Account to lead strategic relationships with IDNs, payers, and large group practices. You will develop account plans, drive market access, and advance reimbursement strategies to improve patient access and product uptake.

The role requires deep knowledge of US reimbursement, Buy & Bill, 340B, and HEOR/RWE; travel up to 60-80% is expected. A strong track record in pharma sales and senior stakeholder engagement is essential.

Qualifications

• Bachelor's degree in life sciences, business, pharmacy, or health economics; MBA/PharmD preferred.
• 5+ years in key account management or market access in pharma/healthcare; dermatology or rare diseases preferred.
• Experience launching products across IDNs, private equity, or Buy & Bill; C-suite selling preferred.
• Willingness to travel 60-80%.

Responsibilities

• Build and manage relationships with key decision-makers within targeted accounts.
• Develop and execute strategic account plans to meet sales targets and maximize growth.
• Gain formulary and protocol access for products within IDNs and Payers.
• Collaborate with Sales, Marketing, Reimbursement, Medical Affairs to support customers.
• Provide guidance and mentorship to less experienced team members.
• Operate in compliance with regulations and maintain transparent communication.

Skills

Key account management

Market access

C-suite selling

Strategic planning

Travel readiness

Education

Bachelor's degree in life sciences, business, pharmacy, or health economics

MBA or PharmD preferred

Job description

LEO Pharma in Denver, CO, is seeking an Associate Director, Key Account to lead strategic relationships with IDNs, payers, and large group practices. You will develop account plans, drive market access, and advance reimbursement strategies to improve patient access and product uptake.

The role requires deep knowledge of US reimbursement, Buy & Bill, 340B, and HEOR/RWE; travel up to 60-80% is expected. A strong track record in pharma sales and senior stakeholder engagement is essential.